Stock Information
Cytokinetics Inc (CYTK)
Ticker Symbol: CYTK
Exchange: NASDAQ
Sector: Biotechnology
Market Cap: $7,607.32 mil
Piotroski score: 2
PE Ratio: N/A
EPS (TTM): -6.5332
Revenue (TTM): $0.72 M
Dividend Yield: N/A%
ROE: -131.19%
Latest News
-
Cytokinetics to Participate in March Investor Conferences
Mon, Mar 2, 2026 9:00 PM
-
Assessing Cytokinetics (CYTK) Valuation After Recent Share Price Weakness And Aficamten Expectations
Mon, Mar 2, 2026 7:08 AM
-
Leerink Partners Maintains Outperform on Cytokinetics, Raises Price Target to $84
Thu, Feb 26, 2026 3:37 PM
-
Cytokinetics, Incorporated Q4 2025 Earnings Call Summary
Thu, Feb 26, 2026 1:03 AM
-
CYTK Posts a Wider-Than-Expected Q4 Loss, Advances Myqorzo Launch Plans
Wed, Feb 25, 2026 6:43 PM
-
Cytokinetics shares are trading lower after the company reported worse-than-expected Q4 EPS results.
Wed, Feb 25, 2026 1:04 PM
-
Citizens Maintains Market Outperform on Cytokinetics, Raises Price Target to $96
Wed, Feb 25, 2026 8:24 AM
-
Needham Maintains Buy on Cytokinetics, Raises Price Target to $85
Wed, Feb 25, 2026 6:34 AM
-
Cytokinetics Inc (CYTK) Q4 2025 Earnings Call Highlights: Strong Financial Position Amid Rising ...
Wed, Feb 25, 2026 5:04 AM
-
Cytokinetics Q4 Earnings Call Highlights
Wed, Feb 25, 2026 4:11 AM
Key Financials
Financial data not available